Skip directly to site content
Skip directly to search
Español
|
Other Languages
Use of COVID-19 Vaccines in the United States
Interim Clinical Considerations
Print
Minus
Related Pages
Get Email Updates
Receive email updates about this page.
What’s this?
COVID-19 Vaccines, Recommendations, and Schedules
Overview of COVID-19 vaccines and vaccination
Routine COVID-19 vaccination guidance
COVID-19 vaccination guidance for people who are immunocompromised
Implementation
Age transitions and simultaneous administration
Interchangeability of COVID-19 vaccines
COVID-19 vaccination and SARS-CoV-2 laboratory testing
Patient counseling
Safety
Contraindications and precautions
Reporting of vaccine adverse events
Safety considerations for mRNA COVID-19 vaccines: Moderna and Pfizer-BioNTech
Safety considerations for Novavax COVID-19 Vaccine
COVID-19 vaccination and myocarditis and pericarditis
Special Situations and Populations
COVID-19 vaccination and prior SARS-CoV-2 infection
COVID-19 vaccination and MIS-C and MIS-A
Pregnancy, lactation, and fertility
Appendices
People who received COVID-19 vaccine outside the United States (Appendix A)
Vaccine administration errors and deviations (Appendix B)
References and Previous Updates
Key References
Previous Updates
Last Reviewed:
October 31, 2024
Source: